@goatfield1
Active 10 months, 2 weeks ago
le to move toward human trials. Adjuvant surgical methods such as TAI show promise in humans but require more robust clinical evaluation.
There is preliminary evidence that adjuvant treatments may mitigate the effects of ischemia/reperfusion injury. However, the pool of investigated pharmacological agents is wide, yet remarkably shallow; most […] View